Stock Market News
Latest stock market news, company updates, earnings coverage and analysis of major global equities
-
MP Materials Rebounds 5.66% as Q4 Magnet Shipments Come Into Focus
MP Materials shares bounced 5.66% to $48 after a steep September pullback, as investors refocused on improving fundamentals and planned…
-
Amazon Stock Faces Capex Test After AWS Growth Hits 36.7%
Amazon delivered record quarterly revenue and its fastest AWS growth in years, yet the stock has lagged as investors focus…
-
SCHD ETF Faces Rate Pressure After 20% Run in 2026
SCHD has been one of the strongest dividend ETFs of 2026, but rising Treasury yields and fresh fund outflows are…
-
Oracle Stock at $132.60: Revenue Growth Meets Capex and Credit Pressure
Oracle shares have fallen sharply even as revenue growth accelerates, with investors focusing on heavy capital spending, negative free cash…
-
Iovance Stock Jumps 24% After $55 Million Revenue Guidance Raise
Iovance Biotherapeutics surged after lifting its 2026 revenue outlook by $55 million, driven by accelerating demand for Amtagvi in advanced…
-
U.S. Stocks Stall as Treasury Yields Climb; FICO Sinks 21.6%, Carnival Jumps 11.8%
U.S. equities were little changed in late trading as rising Treasury yields capped any rebound attempt. Fair Isaac plunged after…
-
McDonald’s Stock Slumps 31% as Investor Day Raises Turnaround Doubts
McDonald’s shares are heading for their weakest year since 2002 after management signaled soft U.S. sales and analysts cut forecasts.…
-
China Stocks Hit One-Year Low as US Curbs Pressure Optical Suppliers
China stocks fell sharply on September 28, 2026, with the CSI 300 sliding to a one-year low as proposed US…
-
Apple iPhone 18 Demand in China Faces Early Test as Premium Models Lose Resale Heat
Early signals suggest Apple’s iPhone 18 Pro and Pro Max are seeing softer demand in China and Hong Kong, with…
-
Kodiak Sciences Soars 160% After DAYBREAK Phase 3 Wet AMD Win
Kodiak Sciences shares surged after its DAYBREAK Phase 3 trial met primary endpoints for two retinal drug candidates. The result…